University of Arizona
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arizona sits in the top decile of US sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count).
University of Arizona: 349 sponsored US clinical trials, 56 recruiting.
University of Arizona sponsors 349 registered US clinical trials on ClinicalTrials.gov, 56 of them currently recruiting, and 213 completed. 21 of these trials are in Phase 3-4 (later-stage) and 100 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 6 trials.
Top-decile sponsor footprint
University of Arizona ranks in the top decile of sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
213 of 260 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
349 total, page 4 of 7
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
NCT03748303
Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF
NCT05359965
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240
Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting
NCT03998878
ED-Initiated School-based Asthma Medication Supervision
NCT03952286
Mitochondrial Methylation in Type 2 Diabetes
NCT04126551
Type 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and Mothers
NCT03781102
Evaluating the Effect of Bathing Additives in Atopic Dermatitis
NCT04001855
IV Steroids Versus Steroids Included in Block for Orthopedic Lower Limb Surgery
NCT03855059
The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes
NCT04796207
Electromyography in Labor and Parturition
NCT03899493
Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
NCT03911453
Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer
NCT03601507
Oxytocin Pathways and the Health Effects of Human-Animal Interaction
NCT03852264
Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy
NCT03602066
Caregivers' and Cancer Survivors' Psychological Distress & Symptom Management
NCT03743415
Menstrual Phase and Smoking Cessation at a State Quitline
NCT03908320
Psilocybin for Treatment of Obsessive Compulsive Disorder
NCT03300947
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
NCT03714828
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets
NCT03661892
Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
NCT03657433
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
NCT03530696
Assessment of Sleep by WHOOP in Ambulatory Subjects
NCT03692195
Innovative Approach to Reduce Lung Cancer Stigma
NCT03750864
Post Hysterectomy Benefits of Retained Cystoscopy Fluid
NCT03646136
Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer
NCT04000464
Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment
NCT03618992
4-methylpyrazole and Acetaminophen Metabolism
NCT03878693
Post-chemotherapy Symptom Management SMART
NCT03494166
Investigational Test of a New Sleep Supplement
NCT03567343
Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy
NCT03578432
A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website
NCT02968381
Fycompa Titration Intervals and Effects on Retention Rate
NCT03457129
Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma
NCT03496844
Evaluation of Post-Exposure Sauna Treatment of Firefighters - A Pilot Study
NCT03429348
Probing Cortical Excitability and Cognitive Function With TMS
NCT03652012
Improving Adherence to ACS Guidelines on Nutrition and Physical Activity in Latinas With Cancer and Their Informal Caregivers
NCT04314479
Multi-center:The Small (14F) Percutaneous Catheter vs. Large (28-40F) Open Chest Tube for Traumatic Hemothorax (P-CAT)
NCT03546764
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome
NCT03665077
Postoperative subQ Pain Control for Spinal Fusion Surgery
NCT03476811
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
NCT03422536
La Vida Buena Childhood Obesity Program
NCT03781856
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
NCT03279328
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
NCT03067974
Family Routines Enhancing Adolescent Diabetes by Optimizing Management
NCT02974309
Efficacy of the Nurtured Heart Approach to Reduce ADHD Behaviors in Children
NCT03685279
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)
NCT03365895
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
NCT03198390
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
NCT03376971
Fall Prevention in Older Adults Study
NCT03176511
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 57 |
| Phase 3 | 8 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the University of Arizona pipeline
56 recruiting of 349 indexed (16% open); 213 completed (61%).
Phase mix: 21 late (III/IV) vs 100 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arizona: open-pipeline peers nationwide
Peers matched on 349 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 349 trials (± recruiting share)
- Montefiore Medical Center · 345 trials · 19% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
Sponsors near 16% open enrollment (± trial volume)
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
- George Mason University · 16% recruiting · 25 trials
- University of California, San Francisco · 16% recruiting · 1,713 trials
- National Human Genome Research Institute (NHGRI) · 16% recruiting · 185 trials
Related
What to do with this University of Arizona page
349 registered trials is a research-attention snapshot, not an endorsement of University of Arizona or any single study.
- 56 of University of Arizona's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of Arizona studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Arizona pipeline card: 349 registered trials from official public datasets.Report a data error.